Skip to main content
. 2021 Aug 30;21(1):102927. doi: 10.1016/j.autrev.2021.102927

Fig. 7.

Fig. 7

Forest plot depicting the pooled odds ratio of seroconversion after SARS-CoV-2 vaccination in patients receiving anti-TNF monotherapy as compared to anti-TNF in combination with an immunomodulator.